Show More
More research is necessary with larger and more varied participants
GLP-1 receptor agonists work through several pathways: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , particularly the hypothalamus, to decrease food intake While these medications are licensed by the MHRA for type 2 diabetes and, in some formulations (e.g., Saxenda, Wegovy), for chronic weight management, NHS access via NICE guidance is more restricted
Smaller portions are often enough
But good quality human clinical trials of the combination are limited and the average effects seen for each on body composition are modest
Hydropersulfides are thought to mediate many of the antioxidant signaling functions once ascribed purely to hydrogen sulfide via modification of protein cysteine (Cys) residues in a process referred to as persulfidation
